LFB Biotechnologies
Records under this name other than patents LFB Biotechnologies holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,364,425 | Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,458,239 | Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II) Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,344,272 | Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,278,423 | Monoclonal Antibodies and Fragment Thereof Directed Against the Human Anti-Mullerian Hormone Type II Receptor (AMHR-II) Formerly held In force · High confidence | In force | High confidence | |
| US 9,234,045 | A Monoclonal Antibody Directed Against CD20 Antigen Formerly held In force · High confidence | In force | High confidence | |
| US RE46,585 | Optimized FC variants Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,012,607 | Novel Mutated Humanized 12G4 Antibodies and the Fragments Thereof Against the Human Anti-Mullerian Hormone Receptor Type II Formerly held In force · High confidence | In force | High confidence | |
| US 9,637,544 | Novel Mutated Humanized 12G4 Antibodies and the Fragments Thereof Against the Human Anti-Mullerian Hormone Receptor Type II Formerly held In force · High confidence | In force | High confidence | |
| US 8,883,450 | Signal peptide, and use thereof for producing recombinant proteins Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,553,712 | Glycols as Pathogen Inactivating Agents Formerly held In force · High confidence | In force | High confidence |